2024-03-29T06:04:35Z
https://soar-ir.repo.nii.ac.jp/oai
oai:soar-ir.repo.nii.ac.jp:00020266
2022-12-14T04:38:32Z
461:462
Malignant Fibrous Histiocytoma with In-Transit Metastasis
Fujimura, Taku
Sugawara, Masayuki
Haga, Takahiro
Kariya, Yoshiyuki
Okuyama, Ryuhei
Tagami, Hachiro
Aiba, Setsuya
© 2011 S. Karger AG, Basel. This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online version of the article only. Distribution for non-commercial purposes only.
Malignant fibrous histiocytoma
CD99
In-transit metastasis
Atypical fibroxanthoma
Malignant fibrous histiocytoma (MFH) is the most common fibroblastic tumor, but its cutaneous metastasis, especially in-transit metastasis, is extremely rare. We describe the case of a 30-year-old Japanese man with a recurrent MFH on the scalp accompanied by in-transit metastasis, which had been treated as a benign skin tumor 8 years before. The main bulk of the recurrent tumor was located in the dermis, but the metastatic tumor was mainly located in the subcutis. Generally, atypical fibroxanthoma, also known as cutaneous MFH, is rarely metastasized and presents a benign clinical course. Since there is a great difference between the prognosis of MFH and atypical fibroxanthoma, precise diagnosis of the primary tumor is essential.
Article
Case reports in dermatology.3:164-169(2011)
S. Karger AG
2011-08-17
eng
journal article
VoR
http://hdl.handle.net/10091/00021024
https://soar-ir.repo.nii.ac.jp/records/20266
https://www.ncbi.nlm.nih.gov/pubmed/21941482
21941482
https://doi.org/10.1159/000331324
10.1159/000331324
1662-6567
AA12780900
Case reports in dermatology
3
164
169
https://soar-ir.repo.nii.ac.jp/record/20266/files/20181109331324.pdf
application/pdf
1.1 MB
2018-11-09